Association between overweight and central interleukin‐6 in a nonclinical adult population
Neuropsychopharmacology Reports · 2024-12 · 44 (4) · 835-841
DOI: 10.1002/npr2.12488 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuropsychopharmacology Reports, online erschienen am 14.10.2024. Verfasst von Takako Enokida und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioresources, Medical Genome Center, National Center of Neurology and Psychiatry, Tokyo, Japan. Hauptthemen laut MEDLINE: Overweight, Interleukin-6, Leptin, C-Reactive Protein. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intramural Research Grant (3-1) for Neurological and Psychiatric Disorders of the NCNP.
Abstract (Originalsprache)
Aim
Overweight is associated with low‐grade systemic inflammation. However, its effect on neuroinflammation remains unclear. We examined the possible association between overweight and neuroinflammation using cerebrospinal fluid (CSF) in a nonclinical adult population in Japan.
Methods
CSF and plasma levels of interleukin‐1β (IL‐1β), interleukin‐6 (IL‐6), tumor necrosis factor‐α (TNF‐α), plasma levels of C‐reactive protein (CRP), and leptin were measured in nonclinical adult participants (35 males and 34 females) who had no current or past history of neuropsychiatric diseases. We performed partial correlation analyses with sex and age as covariates between the body mass index (BMI) and the inflammatory markers and compared them between overweight and nonoverweight participants.
Results
The BMI significantly correlated with CSF levels of IL‐6 (rs = 0.32, p = 0.009), plasma levels of CRP (rs = 0.30, p = 0.016), IL‐1β (rs = 0.29, p = 0.019), IL‐6 (rs = 0.25, p = 0.042), TNF‐α (rs = 0.43, p < 0.001), and leptin (rs = 0.72, p < 0.001). Overweight participants (BMI ≧ 25) had significantly higher CSF levels of IL‐6 ( p < 0.001), plasma levels of IL‐1β ( p = 0.023), TNF‐α ( p < 0.001), and leptin ( p < 0.001) than the nonoverweight participants.
Conclusion
Overweight is associated with central IL‐6, a marker for neuroinflammation, as well as systemic inflammation markers, even in a nonclinical population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioresources, Medical Genome Center, National Center of Neurology and Psychiatry, Tokyo, Japan.
- Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.
- Department of Psychiatry, Teikyo University School of Medicine, Tokyo, Japan.
ORCID-Profile: Kotaro Hattori, Hiroshi Kunugi
Förderung
- Intramural Research Grant (3-1) for Neurological and Psychiatric Disorders of the NCNP
Zitieren
APA
Enokida, T., Hattori, K., Maeda, C., Tomizawa, T., & Kunugi, H. (2024). Association between overweight and central interleukin‐6 in a nonclinical adult population. Neuropsychopharmacology Reports, 44(4), 835-841. https://doi.org/10.1002/npr2.12488
Vancouver
Enokida T, Hattori K, Maeda C, Tomizawa T, Kunugi H. Association between overweight and central interleukin‐6 in a nonclinical adult population. Neuropsychopharmacology Reports. 2024;44(4):835-841. doi:10.1002/npr2.12488
BibTeX
@article{Enokida2024,
author = {Enokida, Takako and Hattori, Kotaro and Maeda, Chiori and Tomizawa, Takahiro and Kunugi, Hiroshi},
title = {Association between overweight and central interleukin‐6 in a nonclinical adult population},
journal = {Neuropsychopharmacology Reports},
year = {2024},
volume = {44},
number = {4},
pages = {835--841},
doi = {10.1002/npr2.12488}
}
EUVIMED